Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Receivables - Net: 2009-2025

Historic Receivables - Net for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $15.2 million.

  • Lifecore Biomedical's Receivables - Net fell 6.90% to $15.2 million in Q2 2025 from the same period last year, while for May 2025 it was $15.2 million, marking a year-over-year decrease of 6.90%. This contributed to the annual value of $15.2 million for FY2025, which is 6.90% down from last year.
  • As of FY2025, Lifecore Biomedical's Receivables - Net stood at $15.2 million, which was down 6.90% from $16.3 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Receivables - Net ranged from a high of $38.8 million in FY2022 and a low of $15.2 million during FY2025.
  • Moreover, its 3-year median value for Receivables - Net was $16.3 million (2024), whereas its average is $20.3 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Receivables - Net slumped by 58.55% in 2021, and later grew by 22.93% in 2022.
  • Over the past 5 years, Lifecore Biomedical's Receivables - Net (Yearly) stood at $31.6 million in 2021, then grew by 22.93% to $38.8 million in 2022, then fell by 24.02% to $29.5 million in 2023, then slumped by 44.85% to $16.3 million in 2024, then dropped by 6.90% to $15.2 million in 2025.